Patents by Inventor Carl Ward

Carl Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240425079
    Abstract: According to an aspect of the disclosure, a method is provided comprising receiving sensor data from a sensor of a vehicle, such as an autonomous vehicle, and determining, based at least in part on the sensor data, a subset of motion options from a predetermined set of motions options associated with controlling the vehicle. A representation of the subset of motion options is transmitted to a remote system. A first motion option of the subset of motion options is received from the remote system, and the vehicle is controlled based at least in part on the first motion option.
    Type: Application
    Filed: June 22, 2023
    Publication date: December 26, 2024
    Inventors: Erik Carl WARD, Ravi GOGNA
  • Publication number: 20240173428
    Abstract: Provided herein, inter alia, are methods and compounds for targeted autophagy.
    Type: Application
    Filed: April 18, 2023
    Publication date: May 30, 2024
    Inventors: Daniel K. Nomura, Roberto Zoncu, Carl Ward, Sin Ki Fung, Chris Kumar Varma, Benjamin Fontaine
  • Publication number: 20230407245
    Abstract: Provided are media and methods for establishing and maintaining mammalian early embryo-like cells. The culture media can be used to culture mammalian pluripotent stem cells (PSCs), are chemically defined, and comprise basal media for culturing stem cells supplemented with a S-adenosylhomocysteine hydrolase (SAH)/Polycomb repressive complexes (PRC)/EZH2 inhibitor and a histone deacetylase (HDAC) inhibitor. With the culture media thereof, primate (human and non-human) PSCs can be converted to preimplantation ICM-like cells (ICLCs) or 8-cell embryo-like cells (8CLCs).
    Type: Application
    Filed: November 11, 2020
    Publication date: December 21, 2023
    Inventors: Miguel A. Esteban, Md. Abdul Mazid, Wenjuan Li, Zhiwei Luo, Carl Ward, Yunpan Li, Yiwei Lai
  • Publication number: 20230407249
    Abstract: Provided are media and methods for establishing and maintaining mammalian early embryo-like cells. The culture media can be used to culture mammalian pluripotent stem cells (PSCs), which is chemically defined and comprises basal media for culturing stem cells supplemented with a S-adenosylhomocysteine hydrolase (SAH)/Polycomb repressive complexes (PRC)/EZH2 inhibitor, a histone deacetylase (HDAC) inhibitor and a WNT/?-catenin signaling/tankyrase inhibitor. With the culture media, primate (human and non-human) PSCs can be converted to preimplantation ICM-like cells (ICLCs) or 8-cell embryo-like cells (8CLCs).
    Type: Application
    Filed: November 10, 2021
    Publication date: December 21, 2023
    Inventors: Miguel A. Esteban, Md. Abdul Mazid, Wenjuan Li, Zhiwei Luo, Carl Ward, Yunpan Li, Yiwei Lai
  • Patent number: 11666661
    Abstract: Provided herein, inter alia, are methods and compounds for targeted autophagy.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 6, 2023
    Assignees: The Regents of the University of California, Frontier Medicines Corporation
    Inventors: Daniel K. Nomura, Roberto Zoncu, Carl Ward, Sin Ki Fung, Chris Kumar Varma, Benjamin Fontaine
  • Publication number: 20220235321
    Abstract: The invention relates to methods of generating hepatic cells by overexpressing combinations of transcription factors, in particular for use in cellular reprogramming methods.
    Type: Application
    Filed: February 7, 2022
    Publication date: July 28, 2022
    Inventors: Tüzer Kalkan, Thomas Pierre Michel Moreau, Carl Ward, Tildon Grant Belgard, Fabian Bachinger
  • Patent number: 11274279
    Abstract: The invention relates to methods of generating hepatic cells by overexpressing combinations of transcription factors, in particular for use in cellular reprogramming methods.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: March 15, 2022
    Assignee: Bit Bio Limited
    Inventors: Tüzer Kalkan, Thomas Pierre Michel Moreau, Carl Ward, Tildon Grant Belgard, Fabian Bachinger
  • Publication number: 20210284960
    Abstract: The invention relates to methods of generating hepatic cells by overexpressing combinations of transcription factors, in particular for use in cellular reprogramming methods.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 16, 2021
    Inventors: Tüzer Kalkan, Thomas Pierre Michel Moreau, Carl Ward, Tildon Grant Belgard, Fabian Bachinger
  • Publication number: 20190290778
    Abstract: Provided herein, inter alia, are methods and compounds for targeted autophagy.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Inventors: Daniel K. Nomura, Roberto Zoncu, Carl Ward, Sin Ki Fung, Chris Kumar Varma, Benjamin Fontaine
  • Patent number: 8204779
    Abstract: A high performance capability assessment model helps a revenue industry agency meet the challenges of the global marketplace. As a result, the revenue industry can achieve the clarity, consistency, and well-defined execution of core processes that reduce inefficiencies and waste that result from unnecessary process complexity and exceptions. In addition, the high performance capability assessment model helps the revenue industry agency to identify specific areas in which improvements may be made and understand how to make the improvements, and establishes levels of capability along the way to reaching an ultimate capability goal.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: June 19, 2012
    Assignee: Accenture Global Services Limited
    Inventors: Roderick R. Hughes, Christine E. Denzer, Ruth A. Kennedy, Chen Ming, Shannon N. Johnson, David Regan, Carl Ward, Matthew A. Newman, Peter C. Olds, Karla J. Hulett, Lucina O'Sullivan
  • Publication number: 20090234684
    Abstract: A system for receiving and processing data includes a data processing and verification component that accepts data from a client in an electronic format and identifies therefrom data elements that can be directly verified. A risk assessment component receives data elements that have not been identified as directly verifiable and assesses a risk that the data elements are incomplete or incorrect. The risk assessment component generates risk assessment data. A decision support component receives the risk assessment data from the risk assessment component and selects appropriate actions for subsequent processing of the client data according to the assessment of risk contained in the risk assessment data.
    Type: Application
    Filed: March 24, 2006
    Publication date: September 17, 2009
    Inventors: Mark Peter Stoke, Carl Ward
  • Patent number: 7270590
    Abstract: A toy doll may include a body supported by a skeletal structure including one or more joint assemblies. A joint assembly may include a pivot block further including a pivot stop, and a joint member rotatably coupled to the pivot block, the joint member further including a stop protrusion configured to engage the pivot stop upon rotation of the joint member in a predetermined direction, wherein engagement of the pivot stop prevents further rotation of the joint member in a predetermined direction, wherein the joint member is moveable through a predetermined range of motion transverse to the plane of rotation of the joint member, and wherein movement of the joint member transverse to the plane of rotation allows the stop protrusion to bypass the pivot stop.
    Type: Grant
    Filed: February 17, 2005
    Date of Patent: September 18, 2007
    Assignee: Mattel, Inc.
    Inventors: Jon C. Marine, Joe Carl Ward, Elizabeth Libretti
  • Patent number: 5798107
    Abstract: The present invention relates to a wrinkle reducing composition for use on fabrics, particularly clothing. The composition comprises a wrinkle reducing active, which is made up of an effective amount of silicone and an effective amount of film-forming polymer, and a liquid carrier. The composition is substantially free of starch, modified starch, and mixtures thereof, and results a Loss Modulus Difference of greater than about 3.3.times.10.sup.7 Pascal on fabric. The composition can be incorporated into a spray dispenser that can create an article of manufacture which facilitates treatment of the fabric with the wrinkle reducing composition. The wrinkle reducing actives in the composition can be determined through Dynamic Mechanical Analysis using a 100% cotton broadcloth swatch and a fixed volume of a sample of wrinkle reducing active.
    Type: Grant
    Filed: June 24, 1996
    Date of Patent: August 25, 1998
    Assignee: The Procter & Gamble Company
    Inventors: Alice Marie Vogel, Errol Hoffman Wahl, Jerome Paul Cappel, Thomas Carl Ward